Skip to main content
Log in

Risk factors for systemic fungal infections in liver transplant recipients

  • Article
  • Published:
European Journal of Clinical Microbiology and Infectious Diseases Aims and scope Submit manuscript

Abstract

The risk factors for systemic fungal infections were analysed retrospectively in 186 orthotopic liver transplant procedures performed in 152 patients between June 1985 and January 1993. The total incidence of systemic fungal infections was 16.5 % (25/152). The incidence of disseminated candidiasis, aspergillosis, and combined candidiasis and aspergillosis was 6.5 % (n=10), 7.2 % (n=11) and 2.6 % (n=4), respectively. Mortality associated with systemic fungal infections was 80 % (20 of 25 patients). There were ten cases of disseminated candidiasis, with 4 patients surviving, and 11 cases of invasive aspergillosis, with 1 patient surviving. All patients with combined systemic fungal infection died. To identify perioperative risk factors, 39 variables were used to compare patients with systemic fungal infections versus those without fungal infections. Fourteen variables were significantly associated with systemic fungal infections by univariate analysis. A consecutive logistic regression analysis revealed that the amount of fresh frozen plasma transfused due to poor initial function of the allograft and acute renal failure requiring hemofiltration were independently significant risk factors for systemic fungal infections. There was no statistical correlation between systemic fungal infections and the underlying liver disease, previous long-term corticosteroids and the postoperative immunosuppressive therapy. Risk factors identified in this study should be considered in the postoperative care of the individual liver transplant recipient. In our study a poor initial function of the hepatic allograft substantially increased the risk of systemic fungal infection.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Schröter GPJ, Hoelscher M, Putnam CW, Porter KA, Starzl TE: Fungus infections after liver transplantation. Annals of Surgery 1977, 156: 115–122.

    Google Scholar 

  2. Wajszczuk CP, Dummer JS, Ho M, Van Thiel DH, Starzl TE, Iwatsuki S: Fungal infections in liver transplant recipients. Transplantation 1985, 40: 347–353.

    PubMed  Google Scholar 

  3. Kusne S, Dummer JS, Singh N, Makowka L, Esquivel C, Starzl TE: Fungal infections after liver transplantation. Transplantation Proceedings 1988, 20: 650–651.

    Google Scholar 

  4. Colonna JO, Winston DJ, Brill JE, Goldstein LI, Hoff MP, Hiatt JR: Infectious complications in liver transplantation. Archives of Surgery 1988, 123: 360–364.

    PubMed  Google Scholar 

  5. Castaldo P, Stratta RJ, Wood RP, Markin RS, Patil KD, Shaefer MS: Clinical spectrum of fungal infections after orthotopic liver transplantation. Archives of Surgery 1991, 126: 149–156.

    PubMed  Google Scholar 

  6. Collins LA, Samore MH, Roberts MS, Luzzati R, Jenkins RL, Lewis WD, Karchmer AW: Risk factors for invasive fungal infections complicating orthotopic liver transplantation. Journal of Infectious Diseases 1994, 170: 644–652.

    PubMed  Google Scholar 

  7. Paya CV: Fungal infections in solid-organ transplantation. Clinical Infectious Diseases 1993, 16: 677–688.

    PubMed  Google Scholar 

  8. Unertl K, Ruckdeschel G, Selbmann HK, Jensen U, Forst H, Lenhart FP: Prevention of colonization and respiratory infections in long-term ventilated patients by local antimicrobial prophylaxis. Intensive Care Medicine 1987, 13: 106–113.

    PubMed  Google Scholar 

  9. Haller M, Schönfelder R, Briegel J, Pratschke E, Spengler U, Pfeiffer M: Renal function in the postoperative period after orthotopic liver transplantation. Transplantation Proceedings 1992, 24: 2704–2706.

    PubMed  Google Scholar 

  10. Kusne S, Torre-Cisneros J, Mañez R, Irish W, Martin M, Fung J: Factors associated with invasive lung aspergillosis and the significance of positiveAspergillus culture after liver transplantation. Journal of Infectious Diseases 1992, 166: 1379–1383.

    PubMed  Google Scholar 

  11. Paya CV, Hermans PE, Washington JA, Smith TF, Anhalt JP, Wiesner RH: Incidence, distribution, and outcome of episodes of infection in 100 orthotopic liver transplantations. Mayo Clinic Proceedings 1989, 64: 555–564.

    PubMed  Google Scholar 

  12. Wiesner RH, Hermans PE, Rakela J, Washington JA, Perkins JD, DiCecco S: Selective bowel decontamination to decrease gram negative aerobic bacterial andCandida colonization and prevent infection after orthotopic liver transplantation. Transplantation 1988, 45: 570–574.

    PubMed  Google Scholar 

  13. Rossi G, Tortorano AM, Viviani MA, Pagano A, Colledan M, Fassati LR:Aspergillus fumigatus infections in liver transplant patients. Transplantation Proceedings 1989, 21: 2268–2270.

    PubMed  Google Scholar 

  14. Beyer J, Schwartz S, Heinemann V, Siegert W: Strategies in prevention of invasive pulmonary aspergillosis in immunosuppressed or neutropenic patients. Antimicrobial Agents and Chemotherapy 1994, 38: 911–917.

    PubMed  Google Scholar 

  15. Bodey GP, Vartivarian S: Aspergillosis. European Journal of Clinical Microbiology & Infectious Diseases 1989, 8: 413–437.

    Google Scholar 

  16. Khardori N: Host-parasite interaction in fungal infections. European Journal of Clinical Microbiology & Infectious Diseases 1989, 8: 331–351.

    Google Scholar 

  17. Schaffner A, Douglas H, Braude A: Selective protection against conidia by monouclear and against mycelia by polymorphnuclear phagocytes in resistance toAspergillus. Journal of Clinical Investigation 1982, 69: 617–631.

    PubMed  Google Scholar 

  18. Walsh TJ, Hamilton SR: Disseminated aspergillosis complicating hepatic failure. Archives of Internal Medicine 1983, 143: 1189–1191.

    PubMed  Google Scholar 

  19. Park GR, Drummond GB, Lamb D, Durie TBM, Milne LJR, Lambie AT: Disseminated aspergillosis occurring in patients with respiratory, renal, and hepatic failure. Lancet 1982, ii: 179–183.

    Google Scholar 

  20. Bailey RJ, Woolf IL, Cullens H, Williams R: Metabolic inhibition of polymorphnuclear leukocytes in fulminant hepatic failure. Lancet 1976, i: 1162–1163.

    Google Scholar 

  21. Goodman JL, Winston DJ, Greenfield RA, Chandrasekar PH, Fox B, Kaizer H, Shadduck RK, Shea TC, Stiff P, Friedman DJ, Powderly WG, Silber JL, Horowitz H, Lichtin A, Wolff SN, Mangan KF, Silver SM, Weisdorf D, Ho WG, Gilbert G, Buell D: A controlled trial of fluconazole to prevent fungal infections in patients under-going bone marrow transplantation. New England Journal of Medicine 1992, 326: 845–851.

    PubMed  Google Scholar 

  22. Winston DJ, Chandrasekar PH, Lazarus HM, Goodman JL, Silber JL, Horowitz H, Shadduck RK, Rosenfeld CS, Ho WG, Islam MZ, Buell DN: Fluconazole prophylaxis of fungal infections in patients with acute leukemia. Annals of Internal Medicine 1993, 118: 495–503.

    PubMed  Google Scholar 

  23. Beyer J, Schwartz S, Barzen G, Risse G, Dullenkopf K, Weyer C: Use of amphotericin B aerosols for the prevention of pulmonary aspergillosis. Infection 1994, 22: 143–148.

    PubMed  Google Scholar 

  24. Husberg BS, Olson LM, Neely SJ, Nery JR, Klintmalm GB: Prophylactic low-dose amphotericin B treatment prevents invasiveCandida infection in high-risk liver transplant patients. Transplantation Proceedings 1988, 20, Supplement 1: 659–660.

    PubMed  Google Scholar 

  25. Caillot D, Chavanet P, Casasnovas O, Solary E, Zanetta G, Buisson M: Clinical evaluation of a new lipid-based delivery system for intravenous administration of amphotericin B. European Journal of Clinical Microbiology & Infectious Diseases 1992, 11: 722–725.

    Google Scholar 

  26. Cowie F, Meller ST, Cushing P, Pinkerton R: Chemoprophylaxis for pumonary aspergillosis during intensive chemotherapy. Archives of Disease in Childhood 1994, 70: 136–138.

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Briegel, J., Forst, H., Spill, B. et al. Risk factors for systemic fungal infections in liver transplant recipients. Eur. J. Clin. Microbiol. Infect. Dis. 14, 375–382 (1995). https://doi.org/10.1007/BF02114892

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02114892

Keywords

Navigation